RobertChinRobert Chin41.78927490000000-87.60125000000000544Chin, RobertAssistant Professorplugins:TwitterTwitterprns:coAuthorOfcoauthor ofprns:emailEncryptedemail addressprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:physicalNeighborOfphysical neighborprns:pluginSearchableDataProfilesRNS Plugin Searchable Dataprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkAnchorTextlink anchor textvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titleURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonSurgery-Colon and Rectal SurgeryRadiation and Cellular OncologyAuthorship 108082322308455Volkmer JP, Sahoo D, Chin RK, Ho PL, Tang C, Kurtova AV, Willingham SB, Pazhanisamy SK, Contreras-Trujillo H, Storm TA, Lotan Y, Beck AH, Chung BI, Alizadeh AA, Godoy G, Lerner SP, van de Rijn M, Shortliffe LD, Weissman IL, Chan KSProceedings of the National Academy of Sciences of the United States of AmericaThree differentiation states risk-stratify bladder cancer into distinct subtypes. Proc Natl Acad Sci U S A. 2012 Feb 07; 109(6):2078-83.Proc Natl Acad Sci U S A2012-01-19T00:00:002012Three differentiation states risk-stratify bladder cancer into distinct subtypes.Medicine-GastroenterologyD008233Chemicals & Drugs26440.977938Lymphotoxin-alphaAuthorship 205773Authorship 235431Authorship 206112Authorship 209243Authorship 244134Authorship 255682Authorship 238673Authorship 255949Authorship 240974Authorship 232301Authorship 336432Authorship 306612Authorship 378029Authorship 298531Authorship 303182D014157Chemicals & Drugs40615550.562899Transcription FactorsAuthorship 237842KingaOlorteguiKinga Olortegui41.7886000000000087.598699999999993971Olortegui, KingaAssistant Professor12006975Kang HS, Chin RK, Wang Y, Yu P, Wang J, Newell KA, Fu YXNature immunologySignaling via LTbetaR on the lamina propria stromal cells of the gut is required for IgA production. Nat Immunol. 2002 Jun; 3(6):576-82.Nat Immunol2002-05-13T00:00:002002Signaling via LTbetaR on the lamina propria stromal cells of the gut is required for IgA production.12969319Chin R, Wang J, Fu YXImmunological reviewsLymphoid microenvironment in the gut for immunoglobulin A and inflammation. Immunol Rev. 2003 Oct; 195:190-201.Immunol Rev2003-10-01T00:00:002003Lymphoid microenvironment in the gut for immunoglobulin A and inflammation.12115617Wang J, Foster A, Chin R, Yu P, Sun Y, Wang Y, Pfeffer K, Fu YXEuropean journal of immunologyThe complementation of lymphotoxin deficiency with LIGHT, a newly discovered TNF family member, for the restoration of secondary lymphoid structure and function. Eur J Immunol. 2002 Jul; 32(7):1969-79.Eur J Immunol2002-07-01T00:00:002002The complementation of lymphotoxin deficiency with LIGHT, a newly discovered TNF family member, for the restoration of secondary lymphoid structure and function.14638845Kang HS, Blink SE, Chin RK, Lee Y, Kim O, Weinstock J, Waldschmidt T, Conrad D, Chen B, Solway J, Sperling AI, Fu YXThe Journal of experimental medicineLymphotoxin is required for maintaining physiological levels of serum IgE that minimizes Th1-mediated airway inflammation. J Exp Med. 2003 Dec 01; 198(11):1643-52.J Exp Med2003-11-24T00:00:002003Lymphotoxin is required for maintaining physiological levels of serum IgE that minimizes Th1-mediated airway inflammation.14704792Yu P, Lee Y, Liu W, Chin RK, Wang J, Wang Y, Schietinger A, Philip M, Schreiber H, Fu YXNature immunologyPriming of naive T cells inside tumors leads to eradication of established tumors. Nat Immunol. 2004 Feb; 5(2):141-9.Nat Immunol2004-01-04T00:00:002004Priming of naive T cells inside tumors leads to eradication of established tumors.14517552Chin RK, Lo JC, Kim O, Blink SE, Christiansen PA, Peterson P, Wang Y, Ware C, Fu YXNature immunologyLymphotoxin pathway directs thymic Aire expression. Nat Immunol. 2003 Nov; 4(11):1121-7.Nat Immunol2003-09-28T00:00:002003Lymphotoxin pathway directs thymic Aire expression.11994465Yu P, Wang Y, Chin RK, Martinez-Pomares L, Gordon S, Kosco-Vibois MH, Cyster J, Fu YXJournal of immunology (Baltimore, Md. : 1950)B cells control the migration of a subset of dendritic cells into B cell follicles via CXC chemokine ligand 13 in a lymphotoxin-dependent fashion. J Immunol. 2002 May 15; 168(10):5117-23.J Immunol2002-05-15T00:00:002002B cells control the migration of a subset of dendritic cells into B cell follicles via CXC chemokine ligand 13 in a lymphotoxin-dependent fashion.15368286Lian RH, Chin RK, Nemeth HE, Libby SL, Fu YX, Kumar VEuropean journal of immunologyA role for lymphotoxin in the acquisition of Ly49 receptors during NK cell development. Eur J Immunol. 2004 Oct; 34(10):2699-707.Eur J Immunol2004-10-01T00:00:002004A role for lymphotoxin in the acquisition of Ly49 receptors during NK cell development.15375218Baron BW, Anastasi J, Montag A, Huo D, Baron RM, Karrison T, Thirman MJ, Subudhi SK, Chin RK, Felsher DW, Fu YX, McKeithan TW, Baron JMProceedings of the National Academy of Sciences of the United States of AmericaThe human BCL6 transgene promotes the development of lymphomas in the mouse. Proc Natl Acad Sci U S A. 2004 Sep 28; 101(39):14198-203.Proc Natl Acad Sci U S A2004-09-16T00:00:002004The human BCL6 transgene promotes the development of lymphomas in the mouse.16785524Chin RK, Zhu M, Christiansen PA, Liu W, Ware C, Peltonen L, Zhang X, Guo L, Han S, Zheng B, Fu YXJournal of immunology (Baltimore, Md. : 1950)Lymphotoxin pathway-directed, autoimmune regulator-independent central tolerance to arthritogenic collagen. J Immunol. 2006 Jul 01; 177(1):290-7.J Immunol2006-07-01T00:00:002006Lymphotoxin pathway-directed, autoimmune regulator-independent central tolerance to arthritogenic collagen.14617751Lo JC, Chin RK, Lee Y, Kang HS, Wang Y, Weinstock JV, Banks T, Ware CF, Franzoso G, Fu YXThe Journal of clinical investigationDifferential regulation of CCL21 in lymphoid/nonlymphoid tissues for effectively attracting T cells to peripheral tissues. J Clin Invest. 2003 Nov; 112(10):1495-505.J Clin Invest2003-11-01T00:00:002003Differential regulation of CCL21 in lymphoid/nonlymphoid tissues for effectively attracting T cells to peripheral tissues.17039258Zhu M, Chin RK, Christiansen PA, Lo JC, Liu X, Ware C, Siebenlist U, Fu YXThe Journal of clinical investigationNF-kappaB2 is required for the establishment of central tolerance through an Aire-dependent pathway. J Clin Invest. 2006 Nov; 116(11):2964-71.J Clin Invest2006-10-12T00:00:002006NF-kappaB2 is required for the establishment of central tolerance through an Aire-dependent pathway.14991067Subudhi SK, Zhou P, Yerian LM, Chin RK, Lo JC, Anders RA, Sun Y, Chen L, Wang Y, Alegre ML, Fu YXThe Journal of clinical investigationLocal expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection. J Clin Invest. 2004 Mar; 113(5):694-700.J Clin Invest2004-03-01T00:00:002004Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection.19349616Lee Y, Auh SL, Wang Y, Burnette B, Wang Y, Meng Y, Beckett M, Sharma R, Chin R, Tu T, Weichselbaum RR, Fu YXBloodTherapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment. Blood. 2009 Jul 16; 114(3):589-95.Blood2009-04-06T00:00:002009Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment.18056347Zhu M, Chin RK, Tumanov AV, Liu X, Fu YXJournal of immunology (Baltimore, Md. : 1950)Lymphotoxin beta receptor is required for the migration and selection of autoreactive T cells in thymic medulla. J Immunol. 2007 Dec 15; 179(12):8069-75.J Immunol2007-12-15T00:00:002007Lymphotoxin beta receptor is required for the migration and selection of autoreactive T cells in thymic medulla.D018124Chemicals & Drugs49880.968945Receptors, Tumor Necrosis Factor16934497Lee Y, Chin RK, Christiansen P, Sun Y, Tumanov AV, Wang J, Chervonsky AV, Fu YXImmunityRecruitment and activation of naive T cells in the islets by lymphotoxin beta receptor-dependent tertiary lymphoid structure. Immunity. 2006 Sep; 25(3):499-509.Immunity2006-08-24T00:00:002006Recruitment and activation of naive T cells in the islets by lymphotoxin beta receptor-dependent tertiary lymphoid structure.Authorship 1531771535205686Woods KE, Ma TM, Cook KA, Morris ED, Gao Y, Sheng K, Kishan AU, Hegde JV, Felix C, Basehart V, Narahara K, Shen Z, Tenn S, Steinberg ML, Chin RK, Cao MCancersA Prospective Phase II Study of Automated Non-Coplanar VMAT for Recurrent Head and Neck Cancer: Initial Report of Feasibility, Safety, and Patient-Reported Outcomes. Cancers (Basel). 2022 Feb 14; 14(4).Cancers (Basel)2022-02-14T00:00:002022A Prospective Phase II Study of Automated Non-Coplanar VMAT for Recurrent Head and Neck Cancer: Initial Report of Feasibility, Safety, and Patient-Reported Outcomes.https://rubinlab.uchicago.edu/Rubin Lab Sitehttps://www.uchicagomedicine.org/conditions-services/inflammatory-bowel-diseaseInflammatory Bowel Disease CenterIBDMDD013950Anatomy761950.908397Thymus GlandD024043Chemicals & Drugs11140.992456Collagen Type IIMedicinePathologyRadiation OncologyUniversity of ChicagoArifShaikhArif Shaikh41.78927490000000-87.601250000000001196Shaikh, ArifClinical Assistant ProfessorEugene B.Chang0mBqA6AbHszMknJtY0fp/Cv/+94=Eugene B. Chang41.78927490000000-87.601250000000001255Chang, Eugene B.ProfessorEzraCohenEzra Cohen41.78927490000000-87.601250000000001350Cohen, EzraASSOCIATE PROFESSORByronBurnetteByron Burnette41.78927490000000-87.601250000000001633Burnette, ByronPostdoctoral ScholarRyanWidauRyan Widau41.78927490000000-87.6012500000000018Widau, RyanPostdoctoral ScholarSamuelHellmanSamuel Hellman41.78927490000000-87.601250000000001875Hellman, SamuelEmeritus/Emerita, ProfessorVinayKumarVinay Kumar41.78927490000000-87.601250000000002039Kumar, VinayProfessorRalph R.WeichselbaumxXB+DqgWEf/5hHlsaUXv9Gq0+s+oRalph R. Weichselbaum41.78927490000000-87.601250000000002521Weichselbaum, Ralph R.ProfessorDavid T.RubinDavid T. Rubin41.78927490000000-87.60125000000000256Rubin, David T.ProfessorBrianBudkeBrian Budke41.78927490000000-87.601250000000002603Budke, BrianPostdoctoral ScholarThomas F.GajewskiThomas F. Gajewski41.78927490000000-87.60125000000000355Gajewski, Thomas F.Professor0.840340.00781251203research areas0.1715590.015192320coauthor of7.700421.7116860similar to1123selected publicationsYusukeNakamuraYusuke Nakamura41.78927490000000-87.60125000000000582Nakamura, YusukeEmeritus/Emerita, ProfessorDianaBolotinDiana Bolotin41.78927490000000-87.60125000000000646Bolotin, DianaAssociate Professortrue1ProfessorProfessortrue1Emeritus/Emerita, ProfessorEmeritus/Emerita, Professortrue1ASSOCIATE PROFESSORASSOCIATE PROFESSORtrue1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Postdoctoral ScholarPostdoctoral Scholartrue1Assistant ProfessorAssistant Professortrue1Postdoctoral ScholarPostdoctoral Scholartrue1Clinical Assistant ProfessorClinical Assistant Professortrue1Emeritus/Emerita, ProfessorEmeritus/Emerita, Professortrue1Postdoctoral ScholarPostdoctoral Scholartrue1Assistant ProfessorAssistant ProfessorAuthorship 758703Authorship 78103424758726Kamaria M, Shea CR, Chin RK, Cohen EE, Maggiore R, Bolotin DClinical and experimental dermatologyEruptive cutaneous squamous cell carcinoma and psoriasis: response to cetuximab. Clin Exp Dermatol. 2014 Jul; 39(5):604-7.Clin Exp Dermatol2014-04-23T00:00:002014Eruptive cutaneous squamous cell carcinoma and psoriasis: response to cetuximab.Chicago60637ILMedicine-DermatologyAuthorship 532301Authorship 5486169614916Chin RK, Hawkins AL, Isaacs WB, Griffin CACancer genetics and cytogeneticsE1A transformed normal human prostate epithelial cells contain a 16q deletion. Cancer Genet Cytogenet. 1998 Jun; 103(2):155-63.Cancer Genet Cytogenet1998-06-01T00:00:001998E1A transformed normal human prostate epithelial cells contain a 16q deletion.12864967Bodner A, Toth PT, Oh SB, Lu M, Tran PB, Chin RK, Ren D, Miller RJJournal of neuroimmunologyCD4 dependence of gp120IIIB-CXCR4 interaction is cell-type specific. J Neuroimmunol. 2003 Jul; 140(1-2):1-12.J Neuroimmunol2003-07-01T00:00:002003CD4 dependence of gp120IIIB-CXCR4 interaction is cell-type specific.23453331Saloura V, Langerman A, Rudra S, Chin R, Cohen EESurgical oncology clinics of North AmericaMultidisciplinary care of the patient with head and neck cancer. Surg Oncol Clin N Am. 2013 Apr; 22(2):179-215.Surg Oncol Clin N Am2013-02-04T00:00:002013Multidisciplinary care of the patient with head and neck cancer.Authorship 956781227775025Skowron KB, Pitroda SP, Namm JP, Balogun O, Beckett MA, Zenner ML, Fayanju O, Huang X, Fernandez C, Zheng W, Qiao G, Chin R, Kron SJ, Khodarev NN, Posner MC, Steinberg GD, Weichselbaum RRScientific reportsBasal Tumor Cell Isolation and Patient-Derived Xenograft Engraftment Identify High-Risk Clinical Bladder Cancers. Sci Rep. 2016 10 24; 6:35854.Sci Rep2016-10-24T00:00:002016Basal Tumor Cell Isolation and Patient-Derived Xenograft Engraftment Identify High-Risk Clinical Bladder Cancers.